Tag: Clearmind Medicine - Page 2 - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Post published:May 19, 2023
Post category:Press Release

Read more about the article Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity

Post published:May 17, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder

Clearmind Medicine Announces IRB Approval to Conduct Clinical Trial on Alcohol Use Disorder

Post published:May 12, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces Granting of Stock and Warrants

Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces Granting of Stock and Warrants

Post published:May 10, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph Tam

Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph Tam

Post published:May 8, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Clinical Supply Agreement for its Upcoming Clinical Trial

Clearmind Medicine Announces Clinical Supply Agreement for its Upcoming Clinical Trial

Post published:May 2, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Forms a Data and Safety Monitoring Board to Oversee its First-in-Human Clinical Trial

Clearmind Medicine Forms a Data and Safety Monitoring Board to Oversee its First-in-Human Clinical Trial

Post published:April 27, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression

Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression

Post published:April 21, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human Clinical Trial

Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human Clinical Trial

Post published:April 20, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Closes US$3.5 Million Public Offering

Clearmind Medicine Closes US$3.5 Million Public Offering

Post published:April 6, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.